AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Clinical trial NCT05184868 · COMPLETED

Trial details

NCT number: NCT05184868
Sponsor: Arecor Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2022-01-03
Primary completion: 2022-09-09
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.